SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form PRE 14A - Other preliminary proxy statements:
SEC Accession No. 0001144204-17-042072
Filing Date
2017-08-10
Accepted
2017-08-10 16:34:35
Documents
5
Period of Report
2017-08-10

Document Format Files

Seq Description Document Type Size
1 PRE 14A v472901_pre14a.htm PRE 14A 154909
2 GRAPHIC plx_logo.jpg GRAPHIC 8836
3 GRAPHIC proxycard1.jpg GRAPHIC 348835
4 GRAPHIC proxycard2.jpg GRAPHIC 56403
5 GRAPHIC sig.jpg GRAPHIC 4021
  Complete submission text file 0001144204-17-042072.txt   732438
Mailing Address 2 SNUNIT ST SCIENCE PARK, POB 455 CARMIEL L3 20100
Business Address 2 SNUNIT ST SCIENCE PARK, POB 455 CARMIEL L3 20100 972-4-988-9488
Protalix BioTherapeutics, Inc. (Filer) CIK: 0001006281 (see all company filings)

IRS No.: 650643773 | State of Incorp.: DE | Fiscal Year End: 1231
Type: PRE 14A | Act: 34 | File No.: 001-33357 | Film No.: 171021877
SIC: 2836 Biological Products, (No Diagnostic Substances)